{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:42:56Z","timestamp":1767832976009,"version":"3.49.0"},"reference-count":83,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>ADP-ribosylation is a reversible post-translational protein modification, which is evolutionarily conserved in prokaryotic and eukaryotic organisms. It governs critical cellular functions, including, but not limited to cellular proliferation, differentiation, RNA translation, and genomic repair. The addition of one or multiple ADP-ribose moieties can be catalysed by poly(ADP-ribose) polymerase (PARP) enzymes, while in eukaryotic organisms, ADP-ribosylation can be reversed through the action of specific enzymes capable of ADP-ribose signalling regulation. In several lower eukaryotic organisms, including Trypanosomatidae parasites, ADP-ribosylation is thought to be important for infection establishment. Trypanosomatidae encompasses several human disease-causing pathogens, including Trypanosoma cruzi, T. brucei, and the Leishmania genus. These parasites are the etiological agents of Chagas disease, African trypanosomiasis (sleeping sickness), and leishmaniasis, respectively. Currently, licenced medications for these infections are outdated and often result in harmful side effects, and can be inaccessible to those carrying infections, due to them being classified as neglected tropical diseases (NTDs), meaning that many infected individuals will belong to already marginalised communities in countries already facing socioeconomic challenges. Consequently, funding to develop novel therapeutics for these infections is overlooked. As such, understanding the molecular mechanisms of infection, and how ADP-ribosylation facilitates infection establishment by these organisms may allow the identification of potential molecular interventions that would disrupt infection. In contrast to the complex ADP-ribosylation pathways in eukaryotes, the process of Trypanosomatidae is more linear, with the parasites only expressing one PARP enzyme, compared to the, at least, 17 genes that encode human PARP enzymes. If this simplified pathway can be understood and exploited, it may reveal new avenues for combatting Trypanosomatidae infection. This review will focus on the current state of knowledge on the importance of ADP-ribosylation in Trypanosomatidae during infection establishment in human hosts, and the potential therapeutic options that disrupting ADP-ribosylation may offer to combat Trypanosomatidae.<\/jats:p>","DOI":"10.3390\/pathogens12050708","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:49:51Z","timestamp":1683888591000},"page":"708","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Roles of ADP-Ribosylation during Infection Establishment by Trypanosomatidae Parasites"],"prefix":"10.3390","volume":"12","author":[{"given":"Joshua","family":"Dowling","sequence":"first","affiliation":[{"name":"School of Science & Technology, Nottingham Trent University, Nottingham NG11 8NS, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9694-4230","authenticated-orcid":false,"given":"Craig L.","family":"Doig","sequence":"additional","affiliation":[{"name":"School of Science & Technology, Nottingham Trent University, Nottingham NG11 8NS, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1016\/S0021-9258(19)69701-2","article-title":"The branching and linear portions of poly(adenosine diphosphate ribose) have the same alpha(1 leads to 2) ribose-ribose linkage","volume":"256","author":"Miwa","year":"1981","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jprot.2011.07.003","article-title":"Strategies for the identification of arginine ADP-ribosylation sites","volume":"75","author":"Laing","year":"2011","journal-title":"J. Proteom."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1101\/gad.334425.119","article-title":"The impact of PARPs and ADP-ribosylation on inflammation and host\u2013pathogen interactions","volume":"34","author":"Fehr","year":"2020","journal-title":"Genes Dev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Kuny, C.V., and Sullivan, C.S. (2016). Virus\u2013Host Interactions and the ARTD\/PARP Family of Enzymes. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005453"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Malgras, M., Garcia, M., Jousselin, C., Bodet, C., and L\u00e9v\u00eaque, N. (2021). The Antiviral Activities of Poly-ADP-Ribose Polymerases. Viruses, 13.","DOI":"10.3390\/v13040582"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E10457","DOI":"10.1073\/pnas.1812130115","article-title":"ADP-ribosyl\u2013binding and hydrolase activities of the alphavirus nsP3 macrodomain are critical for initiation of virus replication","volume":"115","author":"Abraham","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.tim.2021.01.002","article-title":"When PARPs Meet Antiviral Innate Immunity","volume":"29","author":"Zhu","year":"2021","journal-title":"Trends Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Chiu, H.-P., Chiu, H., Yang, C.-F., Lee, Y.-L., Chiu, F.-L., Kuo, H.-C., Lin, R.-J., and Lin, Y.-L. (2018). Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral protein. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007166"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"14048","DOI":"10.1073\/pnas.1509745112","article-title":"Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein","volume":"112","author":"Liu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1128\/JVI.00733-12","article-title":"New PARP Gene with an Anti-Alphavirus Function","volume":"86","author":"Atasheva","year":"2012","journal-title":"J. Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molmed.2015.03.002","article-title":"PARP13 and RNA regulation in immunity and cancer","volume":"21","author":"Todorova","year":"2015","journal-title":"Trends Mol. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"33922","DOI":"10.1074\/jbc.M111349200","article-title":"HIV-1 Tat Interaction with RNA Polymerase II C-terminal Domain (CTD) and a Dynamic Association with CDK2 Induce CTD Phosphorylation and Transcription from HIV-1 Promoter","volume":"277","author":"Deng","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1074\/jbc.M408435200","article-title":"Poly(ADP-ribose) Polymerase-1 Is a Negative Regulator of HIV-1 Transcription through Competitive Binding to TAR RNA with Tat\u00b7Positive Transcription Elongation Factor b (p-TEFb) Complex","volume":"280","author":"Parent","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1016\/j.bmc.2012.06.021","article-title":"Discovery and SAR of orally efficacious tetrahydropyridopyridazinone PARP inhibitors for the treatment of cancer","volume":"20","author":"Zhu","year":"2012","journal-title":"Bioorganic Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/s41467-021-23003-4","article-title":"Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells","volume":"12","author":"Xing","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/1743-422X-8-546","article-title":"The interaction between the PARP10 protein and the NS1 protein of H5N1 AIV and its effect on virus replication","volume":"8","author":"Yu","year":"2011","journal-title":"Virol. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eaas9332","DOI":"10.1126\/scisignal.aas9332","article-title":"PARP12 suppresses Zika virus infection through PARP-dependent degradation of NS1 and NS3 viral proteins","volume":"11","author":"Li","year":"2018","journal-title":"Sci. Signal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.micinf.2019.06.002","article-title":"Host poly(ADP-ribose) polymerases (PARPs) in acute and chronic bacterial infections","volume":"21","author":"Miettinen","year":"2019","journal-title":"Microbes Infect."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/00024382-200204000-00008","article-title":"Resistance to Acute Septic Peritonitis in Poly(ADP-ribose) Polymerase-1-Deficient Mice","volume":"17","author":"Soriano","year":"2002","journal-title":"Shock"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.shk.0000108397.56565.4a","article-title":"Inhibition of Poly (ADP-ribose) Polymerase Attenuates Acute Lung Injury in an Ovine Model of Sepsis","volume":"21","author":"Murakami","year":"2004","journal-title":"Shock"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbrc.2004.09.135","article-title":"Genetic and pharmacological inhibition of poly(ADP-ribose) polymerase-1 interferes in the chlamydial life cycle","volume":"324","author":"Ortega","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.it.2018.12.006","article-title":"Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond","volume":"40","author":"Kunze","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/cmi.12442","article-title":"The Streptococcus pyogenes NAD+ glycohydrolase modulates epithelial cell PARylation and HMGB1 release","volume":"17","author":"Chandrasekaran","year":"2015","journal-title":"Cell Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1038\/ncomms3240","article-title":"A systematic analysis of the PARP protein family identifies new functions critical for cell physiology","volume":"4","author":"Vyas","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1093\/emboj\/18.16.4446","article-title":"Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice","volume":"18","author":"Oliver","year":"1999","journal-title":"EMBO J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1038\/s41467-021-24225-2","article-title":"Nuclear ADP-ribosylation drives IFN\u03b3-dependent STAT1\u03b1 enhancer formation in macrophages","volume":"12","author":"Gupte","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.csbj.2021.04.023","article-title":"ADP-ribosylation systems in bacteria and viruses","volume":"19","author":"Ahel","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fmolb.2020.00191","article-title":"Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP)\u2014Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy","volume":"7","author":"Harrision","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"18308","DOI":"10.1073\/pnas.0606526103","article-title":"Poly(ADP-ribose) (PAR) polymer is a death signal","volume":"103","author":"Andrabi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2000902","article-title":"Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1\u2013Dependent Cell Death (Parthanatos)","volume":"4","author":"Wang","year":"2011","journal-title":"Sci. Signal."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/ncomms3164","article-title":"Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities","volume":"4","author":"Barkauskaite","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/s41467-019-08859-x","article-title":"Emerging roles of eraser enzymes in the dynamic control of protein ADP-ribosylation","volume":"10","author":"Ferreira","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.bbrc.2020.04.120","article-title":"PARG has a robust endo-glycohydrolase activity that releases protein-free poly(ADP-ribose) chains","volume":"527","author":"Pourfarjam","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.3389\/fimmu.2017.01172","article-title":"Poly(ADP-Ribose)Polymerase-1 in Lung Inflammatory Disorders: A Review","volume":"8","author":"Sethi","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.2147\/JIR.S300679","article-title":"PARP Inhibitors: An Innovative Approach to the Treatment of Inflammation and Metabolic Disorders in Sepsis","volume":"14","author":"Wasyluk","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.4049\/jimmunol.1701117","article-title":"PARP14 Controls the Nuclear Accumulation of a Subset of Type I IFN\u2013Inducible Proteins","volume":"200","author":"Caprara","year":"2018","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ackley, C., Elsheikh, M., and Zaman, S. (2021). Scoping review of Neglected Tropical Disease Interventions and Health Promotion: A framework for successful NTD interventions as evidenced by the literature. PLoS Negl. Trop. Dis., 15.","DOI":"10.1371\/journal.pntd.0009278"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.idc.2018.10.015","article-title":"American Trypanosomiasis (Chagas Disease)","volume":"33","author":"Echeverria","year":"2019","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sangenito, L.S., Branquinha, M.H., and Santos, A.L.S. (2020). Funding for Chagas Disease: A 10-Year (2009\u20132018) Survey. Trop. Med. Infect. Dis., 5.","DOI":"10.3390\/tropicalmed5020088"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1586\/17512433.2014.909282","article-title":"Potential new clinical therapies for Chagas disease","volume":"7","author":"Bustamante","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"Cecchi","year":"2017","journal-title":"Lancet"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","article-title":"Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)","volume":"12","author":"Kennedy","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: The melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","article-title":"The increase in risk factors for leishmaniasis worldwide","volume":"95","author":"Desjeux","year":"2001","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.drudis.2017.06.004","article-title":"Leishmaniasis drug discovery: Recent progress and challenges in assay development","volume":"22","author":"Zulfiqar","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drudis.2017.09.006","article-title":"Molecular targets and pathways for the treatment of visceral leishmaniasis","volume":"23","author":"Jain","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.biochi.2021.06.015","article-title":"Analysis of the mechanisms of action of isopentenyl caffeate against Leishmania","volume":"189","author":"Oliveira","year":"2021","journal-title":"Biochimie"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: Side effects and toxicity","volume":"26","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13071-016-1461-1","article-title":"Disrupted ADP-ribose metabolism with nuclear Poly (ADP-ribose) accumulation leads to different cell death pathways in presence of hydrogen peroxide in procyclic Trypanosoma brucei","volume":"9","author":"Schlesinger","year":"2016","journal-title":"Parasites Vectors"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fmicb.2018.00020","article-title":"MacroD1 Is a Promiscuous ADP-Ribosyl Hydrolase Localized to Mitochondria","volume":"9","author":"Agnew","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"24213","DOI":"10.1038\/srep24213","article-title":"Proximal ADP-ribose Hydrolysis in Trypanosomatids is Catalyzed by a Macrodomain","volume":"6","author":"Haikarainen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ijpara.2010.11.008","article-title":"Poly(ADP-ribose) polymerase plays a differential role in DNA damage-response and cell death pathways in Trypanosoma cruzi","volume":"41","author":"Larrea","year":"2011","journal-title":"Int. J. Parasitol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"105499","DOI":"10.1016\/j.actatropica.2020.105499","article-title":"Poly(ADP-ribose) metabolism in human parasitic protozoa","volume":"208","year":"2020","journal-title":"Acta Trop."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Otto, H., Reche, P.A., Bazan, F., Dittmar, K., Haag, F., and Koch-Nolte, F. (2005). In silico characterization of the family of PARP-like poly(ADP-ribosyl)transferases (pARTs). BMC Genom., 6.","DOI":"10.1186\/1471-2164-6-139"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijpara.2007.08.003","article-title":"TcPARP: A DNA damage-dependent poly(ADP-ribose) polymerase from Trypanosoma cruzi","volume":"38","author":"Villamil","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/nar\/gkh215","article-title":"Crystal structure of the catalytic fragment of murine poly(ADP-ribose) polymerase-2","volume":"32","author":"Oliver","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves, V.M., Matteucci, K.C., Buzzo, C.L., Miollo, B.H., Ferrante, D., Torrecilhas, A.C., Rodrigues, M.M., Alvarez, J.M., and Bortoluci, K.R. (2013). NLRP3 Controls Trypanosoma cruzi Infection through a Caspase-1-Dependent IL-1R-Independent NO Production. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002469"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10495-013-0822-x","article-title":"Trypomastigotes and amastigotes of Trypanosoma cruzi induce apoptosis and STAT3 activation in cardiomyocytes in vitro","volume":"18","author":"Stahl","year":"2013","journal-title":"Apoptosis"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.exppara.2009.01.004","article-title":"Trypanosoma cruzi: Participation of cholesterol and placental alkaline phosphatase in the host cell invasion","volume":"122","author":"Priotto","year":"2009","journal-title":"Exp. Parasitol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Nogueira, N.P., Saraiva, F.M.S., Sultano, P.E., Cunha, P.R.B.B., Laranja, G.A.T., Justo, G.A., Sabino, K.C.C., Coelho, M.G.P., Rossini, A., and Atella, G.C. (2015). Proliferation and Differentiation of Trypanosoma cruzi inside Its Vector Have a New Trigger: Redox Status. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116712"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Poveda, C., Fresno, M., Giron\u00e8s, N., Martins-Filho, O.A., Ram\u00edrez, J.D., Santi-Rocca, J., Marin-Neto, J.A., Morillo, C., Rosas, F., and Guhl, F. (2014). Cytokine Profiling in Chagas Disease: Towards Understanding the Association with Infecting Trypanosoma cruzi Discrete Typing Units (A BENEFIT TRIAL Sub-Study). PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091154"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11596","DOI":"10.1074\/jbc.M109.076984","article-title":"Trypanosoma cruzi Induces the Reactive Oxygen Species-PARP-1-RelA Pathway for Up-regulation of Cytokine Expression in Cardiomyocytes","volume":"285","author":"Ba","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1462-5822.2011.01636.x","article-title":"Tumour necrosis factor (TNF)-mediated NF-\u03baB activation facilitates cellular invasion of non-professional phagocytic epithelial cell lines by Trypanosoma cruzi","volume":"13","author":"Pinto","year":"2011","journal-title":"Cell. Microbiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1101\/gad.183509.111","article-title":"On PAR with PARP: Cellular stress signaling through poly(ADP-ribose) and PARP-1","volume":"26","author":"Luo","year":"2012","journal-title":"Genes Dev."},{"key":"ref_65","unstructured":"Alonso, G.D., Vilchez Larrea, S.C., and Fern\u00e1ndez Villamil, S.H. (2010). Parasitology Research Trends, Le Novo Science Publishers Inc."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Larrea, S.C.V., Schlesinger, M., Kevorkian, M.L., Flawi\u00e1, M.M., Alonso, G.D., and Villamil, S.H.F. (2013). Host Cell Poly(ADP-Ribose) Glycohydrolase Is Crucial for Trypanosoma cruzi Infection Cycle. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0067356"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Wen, J.J., Yin, Y.W., and Garg, N.J. (2018). PARP1 depletion improves mitochondrial and heart function in Chagas disease: Effects on POLG dependent mtDNA maintenance. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007065"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1038\/s41598-017-03751-4","article-title":"Structural and Biochemical Characterization of Poly-ADP-ribose Polymerase from Trypanosoma brucei","volume":"7","author":"Haikarainen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Niemirowicz, G.T., Cazzulo, J.J., \u00c1lvarez, V.E., and Bouvier, L.A. (2018). Simplified inducible system for Trypanosoma brucei. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0205527"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1021\/bi0301791","article-title":"Regulation of the Enzymatic Catalysis of Poly(ADP-ribose) Polymerase by dsDNA, Polyamines, Mg2+, Ca2+, Histones H1 and H3, and ATP","volume":"43","author":"Kun","year":"2003","journal-title":"Biochemistry"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"van Beek, L., McClay, \u00c9., Patel, S., Schimpl, M., Spagnolo, L., and Maia de Oliveira, T. (2021). Parp power: A structural perspective on parp1, parp2, and parp3 in dna damage repair and nucleosome remodelling. Int. J. Mol. Sci., 2.","DOI":"10.3390\/ijms22105112"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1093\/nar\/gky597","article-title":"Trypanosoma brucei UMSBP2 is a single-stranded telomeric DNA binding protein essential for chromosome end protection","volume":"46","author":"Mishra","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/nar\/gkn104","article-title":"Sequence homology and microhomology dominate chromosomal double-strand break repair in African trypanosomes","volume":"36","author":"Glover","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2915.1997.tb00408.x","article-title":"Control of Trypanosoma brucei brucei infections in tsetse, Glossina morsitans","volume":"11","author":"Welburn","year":"1997","journal-title":"Med. Veter. Entomol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1017\/S1431927616000623","article-title":"Nucleologenesis in Trypanosoma cruzi","volume":"22","author":"De","year":"2016","journal-title":"Microsc. Microanal."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e01541-19","DOI":"10.1128\/mBio.01541-19","article-title":"Causes and Effects of Loss of Classical Nonhomologous End Joining Pathway in Parasitic Eukaryotes","volume":"10","author":"Nenarokova","year":"2019","journal-title":"mBio"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1462-5822.2003.00316.x","article-title":"Abortive infection of Lutzomyia longipalpis insect vectors by aflagellated LdARL-3A-Q70L overexpressing Leishmania amazonensis parasites","volume":"5","author":"Cuvillier","year":"2003","journal-title":"Cell. Microbiol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Sahin, A., Espiau, B., Tetaud, E., Cuvillier, A., Lartigue, L., Ambit, A., Robinson, D.R., and Merlin, G. (2008). The Leishmania ARL-1 and Golgi Traffic. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0001620"},{"key":"ref_79","first-page":"140","article-title":"Bisnaphthalimidopropyl Derivatives as Inhibitors of Leishmania SIR2 Related Protein 1","volume":"5","author":"Tavares","year":"2009","journal-title":"ChemBioChem"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Ronin, C., Costa, D.M., Tavares, J., Faria, J., Ciesielski, F., Ciapetti, P., Smith, T.K., MacDougall, J., Cordeiro-Da-Silva, A., and Pemberton, I.K. (2018). The crystal structure of the Leishmania infantum Silent Information Regulator 2 related protein 1: Implications to protein function and drug design. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193602"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2958.2011.07799.x","article-title":"The Leishmania nicotinamidase is essential for NAD+ production and parasite proliferation","volume":"82","author":"Gazanion","year":"2011","journal-title":"Mol. Microbiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1046\/j.1365-2958.2000.01829.x","article-title":"NADP and NAD utilization in Haemophilus influenzae","volume":"35","author":"Reidl","year":"2000","journal-title":"Mol. Microbiol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Moreira, D., Rodrigues, V., Abengozar, M., Rivas, L., Rial, E., Laforge, M., Li, X., Foretz, M., Viollet, B., and Estaquier, J. (2015). Leishmania infantum Modulates Host Macrophage Mitochondrial Metabolism by Hijacking the SIRT1-AMPK Axis. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1004684"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/5\/708\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:34:03Z","timestamp":1760124843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/5\/708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":83,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["pathogens12050708"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12050708","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]}}}